[acb-diabetics] non-invasive CGM

[Patricia LaFrance-Wolf]

This article originally posted 09 November, 2012 and appeared in
<http://www.diabetesincontrol.com/topics/medical-devices> Medical Devices,
<http://www.diabetesincontrol.com/diabetes-in-control-newsletters/651> Issue
651 

 

 


First Possible Non-Invasive Continuous Glucose Monitor Approved in Europe


C8 MediSensors, Inc. has received Europe's CE Mark approval for its Optical
Non-Invasive CGM System....






Advertisement 

A large number of studies have shown that continuous glucose monitors (CGM)
can improve glycemic control with reduced risk of hypoglycemia. CGMs are
adjunct devices that are intended to complement finger stick blood glucose
tests. Traditional CGMs rely on a needle sensor inserted under the skin,
which can cause pain or discomfort, and pose a risk of infection. In
contrast, the C8 MediSensors Optical Glucose Monitor System harnesses the
power of light to measure glucose levels. Using Raman spectroscopy, a beam
of light is shone into the skin and the resulting vibrations of glucose
molecules are measured to give a glucose reading; all achieved via a small,
pain-free portable monitor, discreetly worn under clothes against the skin.

For added convenience these readings are stored and sent wirelessly to the
user's smartphone for glucose readings at a glance, providing the wearer
with a continuous picture of glucose dynamics throughout the day. A good
understanding of glucose levels is invaluable in managing diabetes and
improving patient outcomes. In clinical studies, the C8 MediSensors monitor
was found to have accuracy comparable to earlierversions of invasive CGMs
when those systems were first introduced, but with less pain and less risk
of infection.

"C8 MediSensors was co-founded by a father trying to help his son living
with diabetes, and as a company, we remain dedicated to helping those with
the disease," said Paul Zygielbaum, CEO of C8 MediSensors. "CE Mark approval
is a landmark step for this unique technology. Our team is hugely excited to
be working to make CGM and the Optical Glucose Monitor System available
throughout Europe."

The C8 MediSensors Optical Glucose Monitor System is not yet shipping but
will soon be available for purchase online via the C8 MediSensors website
only to those in Europe.

The C8 MediSensors Optical Glucose Monitor System is an adjunct device. It
is contraindicated in pregnancy and for those under 18 years of age, as well
as in individuals with very light or very dark skin tones, peripheral
vascular disease or individuals who smoke. 


 

Related Articles

 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://www.acb.org/pipermail/acb-diabetics/attachments/20121111/287acfda/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.gif
Type: application/octet-stream
Size: 43 bytes
Desc: not available
URL: <http://www.acb.org/pipermail/acb-diabetics/attachments/20121111/287acfda/attachment.obj>